I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
Differential response to a combination of full-dose osimert..:
Zhu VW
;
Schrock AB
;
Ali SM
.
https://www.dovepress.com/differential-response-to-a-combination-of-full-dose-osimertinib-and-cr-peer-reviewed-article-LCTT. , 2019
Link:
https://doaj.org/article/92497f75a8b94fb7b5a39d98c3997..
RT Journal T1 <Title>Differential response to a combination of full-dose osimertinib and crizotinib in a patient with EGFR-mutant non-small cell lung cancer and emergent MET amplification</Title> UL https://suche.suub.uni-bremen.de/peid=base-ftdoajarticles:oai:doaj.org_article:92497f75a8b94fb7b5a39d98c3997684&Exemplar=1&LAN=DE A1 Zhu VW A1 Schrock AB A1 Ali SM A1 Ou SI PB Dove Medical Press YR 2019 K1 osimertinib K1 crizotinib K1 EGFR K1 MET K1 amplification K1 erlotinib (3-6) K1 Neoplasms. Tumors. Oncology. Including cancer and carcinogens K1 RC254-282 JF https://www.dovepress.com/differential-response-to-a-combination-of-full-dose-osimertinib-and-cr-peer-reviewed-article-LCTT LK http://dx.doi.org/https://doaj.org/article/92497f75a8b94fb7b5a39d98c3997684 DO https://doaj.org/article/92497f75a8b94fb7b5a39d98c3997684 SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)
